MRI与超声在慢性免疫介导性神经病中的诊断准确性
本研究纳入CIDP 13例、MMN 10例、sSMA 12例及健康志愿者30例,比较定性及半定量MRI与超声鉴别免疫介导性神经病与sSMA的诊断性能。结果显示定性评估肥大和信号增高价值有限,DTI指标可区分各组,超声鉴别免疫介导性神经病与sSMA的曲线下面积最高(0.870)。
要点
- STIR或MRN上定性评估神经肥大和信号增高诊断价值有限。
- DTI指标可区分CIDP、MMN、sSMA和健康对照。
- 超声鉴别免疫介导性神经病与sSMA的AUC最高(0.870)。
核心结论
- 定性评估STIR或MRN上的神经肥大和信号增高价值有限。
- DTI指标可能区分CIDP、MMN和sSMA。
- 目前超声可能是临床环境下最合适的诊断影像辅助手段。
研究设计与样本
- 纳入CIDP 13例、MMN 10例、sSMA 12例及健康志愿者30例。
- 评估臂丛MRI的STIR、MRN和DTI序列及超声神经横截面积。
- 三位对诊断不知情的放射科医生定性评分,并计算组间差异和ROC。
主要发现
- 所有组包括健康对照均可见神经肥大和信号增高。
- 观察者内和观察者间一致性变异较大(ICC分别为0.00-0.811和0.101-0.491)。
- DTI在CIDP、MMN、sSMA和对照间显示部分各向异性、轴向弥散率和径向弥散率显著差异(p < 0.05)。
- 超声在上臂和臂丛的横截面积在CIDP、MMN和sSMA间显示显著差异(p < 0.05)。
- 超声鉴别免疫介导性神经病(CIDP和MMN)与sSMA的曲线下面积最高(0.870)。
临床怎么用
- 临床可优先考虑超声作为鉴别免疫介导性神经病与sSMA的影像辅助手段。
- DTI指标有潜力用于区分CIDP、MMN和sSMA。
- 定性评估STIR或MRN上的神经肥大和信号增高需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess and compare the diagnostic performance of qualitative and (semi-)quantitative MRI and ultrasound for distinguishing chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN) from segmental spinal muscular atrophy (sSMA). METHODS: Patients with CIDP (n = 13), MMN (n = 10), or sSMA (n = 12) and healthy volunteers (n = 30) were included. MRI of the brachial plexus, using short tau inversion recovery (STIR), nerve-specific T2-weighted (magnetic resonance neurography [MRN]), and diffusion tensor imaging (DTI) sequences, was evaluated. Furthermore, with ultrasound, cross-sectional areas of the nerves were evaluated. Three radiologists blinded for diagnosis qualitatively scored hypertrophy and increased signal intensity (STIR and MRN), and intraobserver and interobserver agreement was assessed. For the (semi-)quantitative modalities, group differences and receiver operator characteristics were calculated. RESULTS: Hypertrophy and increased signal intensity were found in all groups including healthy controls. Intraobserver and interobserver agreements varied considerably (intraclass correlation coefficients 0.00-0.811 and 0.101-0.491, respectively). DTI showed significant differences (p < 0.05) among CIDP, MMN, sSMA, and controls for fractional anisotropy, axial diffusivity, and radial diffusivity in the brachial plexus. Ultrasound showed significant differences in cross-sectional area (p < 0.05) among CIDP, MMN, and sSMA in upper arm and brachial plexus. For distinguishing immune-mediated neuropathies (CIDP and MMN) from sSMA, ultrasound yielded the highest area under the curve (0.870). CONCLUSION: Qualitative assessment of hypertrophy and signal hyperintensity on STIR or MRN is of limited value. DTI measures may discriminate among CIDP, MMN, and sSMA. Currently, ultrasound may be the most appropriate diagnostic imaging aid in the clinical setting.
引用
- Oudeman J, Eftimov F, Strijkers GJ, et al. Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies. Neurology. 2019. PMID: 31827006. doi:10.1212/WNL.0000000000008697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。